ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ALT Company Profile and Key Details

NASDAQ : ALT

Altimmune, Inc.

$4.55

0.15+3.41%

At Close 4:00 PM

63.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Altimmune, Inc. (ALT) stock surged +3.41%, trading at $4.55 on NASDAQ, up from the previous close of $4.40. The stock opened at $4.37, fluctuating between $4.37 and $4.62 in the recent session.

Stock Snapshot

4.4

Prev. Close

4.37

Open

350.41M

Market Cap

77.01M

Number of Shares

4.37

Day Low

4.615

Day High

-3.4

P/E Ratio

98.96%

Free Float in %

-1.34

EPS (TTM)

3.32

Book Value

-1.3

Cash Flow per Share

2.07M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	4.41	4.62	4.37	4.55	2.1M
Apr 16, 2025	4.46	4.51	4.32	4.40	1.05M
Apr 15, 2025	4.58	4.71	4.43	4.53	1.26M
Apr 14, 2025	4.70	4.75	4.43	4.63	2.29M
Apr 11, 2025	4.17	4.41	4.12	4.41	1.42M
Apr 10, 2025	4.21	4.28	3.93	4.16	2.1M
Apr 09, 2025	3.60	4.47	3.60	4.23	3.99M
Apr 08, 2025	4.12	4.21	3.55	3.67	2.75M
Apr 07, 2025	4.00	4.22	3.75	3.98	3.55M
Apr 04, 2025	4.30	4.44	4.13	4.24	2.98M
Apr 03, 2025	4.48	4.73	4.43	4.46	2M
Apr 02, 2025	4.67	4.96	4.65	4.78	2.8M
Apr 01, 2025	4.95	5.13	4.70	4.75	2.36M
Mar 31, 2025	5.07	5.12	4.78	5.00	3.59M
Mar 28, 2025	5.57	5.57	5.30	5.32	1.33M
Mar 27, 2025	5.58	5.63	5.45	5.57	1.62M
Mar 26, 2025	5.86	5.92	5.56	5.59	1.43M
Mar 25, 2025	6.01	6.04	5.84	5.89	1.59M
Mar 24, 2025	5.84	6.16	5.82	6.05	2.3M
Mar 21, 2025	5.65	5.87	5.60	5.81	2.04M

Contact Details

Gaithersburg, MD 20878

United States

Website: https://altimmune.comContact: 240 654 1450

About Company

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Frequently Asked Questions

What is the current Altimmune, Inc. (ALT) stock price?

Altimmune, Inc. (NASDAQ: ALT) stock price is $4.55 in the last trading session. During the trading session, ALT stock reached the peak price of $4.62 while $4.37 was the lowest point it dropped to. The percentage change in ALT stock occurred in the recent session was 3.41% while the dollar amount for the price change in ALT stock was $0.15.

ALT's industry and sector of operation?

The NASDAQ listed ALT is part of Biotechnology industry that operates in the broader Healthcare sector. Altimmune, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALT?

Mr. Raymond M. Jordt
Chief Bus. Officer
Mr. José Ochoa
Chief Bus. Officer
Mr. Tony Blandin B.S.
Vice President of Quality & Compliance Management
Mr. Kent A. Tapper BSEE
Corporation Controller
Mr. Richard I. Eisenstadt M.B.A.
Chief Financial Officer
Mr. Bertrand Georges Ph.D.
Chief Technology Officer
Dr. M. Scot Roberts Ph.D.
Chief Scientific Officer
Dr. Vipin K. Garg Ph.D.
Pres, Chief Executive Officer & Director
Mr. Raymond M. Jordt M.B.A.
Chief Bus. Officer
Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS
Chief Medical Officer
Mr. Andrew Shutterly M.S.
Corporation Controller

How ALT did perform over past 52-week?

ALT's closing price is 28.06% higher than its 52-week low of $3.55 where as its distance from 52-week high of $11.16 is -59.23%.

How many employees does ALT have?

Number of ALT employees currently stands at 59.

Link for ALT official website?

Official Website of ALT is: https://altimmune.com

How do I contact ALT?

ALT could be contacted at phone 240 654 1450 and can also be accessed through its website. ALT operates from 910 Clopper Road, Gaithersburg, MD 20878, United States.

How many shares of ALT are traded daily?

ALT stock volume for the day was 2.07M shares. The average number of ALT shares traded daily for last 3 months was 2.49M.

What is the market cap of ALT currently?

The market value of ALT currently stands at $350.41M with its latest stock price at $4.55 and 77.01M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	59
Beta	0.89
Sales or Revenue	$426.00K
5Y Sales Change%	-0.998%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology